Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: innovate UK

New £4.5m initiative launched to address UK medicines manufacturing skills shortage

New £4.5m initiative launched to address UK medicines manufacturing skills shortage
p p Read More

The two-year programme will use virtual reality technology to teach essential skills

October 17, 2024 Department for Science, innovate UK, News, Office for Life Sciences, Resilience Centre of Excellence for UK Medicines Manufacturing Skills, virtual reality

SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK

SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK
p p Read More

The grant will support clinical trials of rare disease therapy for leukodystrophy

August 22, 2024 BioMedical Catalyst grant, innovate UK, leukodystrophy, News, Rare diseases, SynaptixBio

Innovate UK grants £4m to four companies to evaluate biomarkers for dementia

Innovate UK grants £4m to four companies to evaluate biomarkers for dementia
p p Read More

The progressive neurodegenerative disease affects more than 55 million people globally

July 12, 2024 Bio-Hermes-002, Contracts for Innovation, Dementia, Global Alzheimer's Platform Foundation, innovate UK, News, Novo Nordisk

Innovate UK awards ten projects over £6m to develop new clinical tools for dementia

Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year

March 22, 2024 clinical tools, Dementia, innovate UK, neurodegeneration, News, Small Business Research Institute, UK life sciences

Birmingham’s VR-assisted training centre for excellence to support future vaccine makers

The centre will deliver free training, outreach materials and programmes

March 18, 2024 artificial intelligence, innovate UK, Life sciences, News, Office for Life Sciences, RESILIENCE Centre for Excellence for UK Medicines Manufacturing Skills Centre, University of Birmingham, virtual reality
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy